Anti-ATAD1/LILRB2/CD85d monoclonal antibody
The Alternative Names of target: ATAD1, LILRB2, CD85d,Leukocyte immunoglobulin-like receptor subfamily B member 2,LIR-2, Leukocyte immunoglobulin-like receptor 2,CD85 antigen-like family member D, Immunoglobulin-like transcript 4 (ILT-4), Monocyte/macrophage immunoglobulin-like receptor 10 (MIR-10),ILT4,LIR2,CD85D,ILT-4,LIR-2,MIR10,MIR-10
Pre-made anti-ATAD1/LILRB2/CD85d monoclonal antibody (mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research.
Go
to ATAD1/LILRB2/CD85d products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T07931-Ab-1/ GM-Tg-hg-T07931-Ab-2 | Anti-Human ATAD1/LILRB2/CD85d monoclonal antibody | Human |
GM-Tg-rg-T07931-Ab-1/ GM-Tg-rg-T07931-Ab-2 | Anti-Rat ATAD1/LILRB2/CD85d monoclonal antibody | Rat |
GM-Tg-mg-T07931-Ab-1/ GM-Tg-mg-T07931-Ab-2 | Anti-Mouse ATAD1/LILRB2/CD85d monoclonal antibody | Mouse |
GM-Tg-cynog-T07931-Ab-1/ GM-Tg-cynog-T07931-Ab-2 | Anti-Cynomolgus/Rhesus macaque ATAD1/LILRB2/CD85d monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T07931-Ab-1/ GM-Tg-felg-T07931-Ab-2 | Anti-Feline ATAD1/LILRB2/CD85d monoclonal antibody | Feline |
GM-Tg-cang-T07931-Ab-1/ GM-Tg-cang-T07931-Ab-2 | Anti-Canine ATAD1/LILRB2/CD85d monoclonal antibody | Canine |
GM-Tg-bovg-T07931-Ab-1/ GM-Tg-bovg-T07931-Ab-2 | Anti-Bovine ATAD1/LILRB2/CD85d monoclonal antibody | Bovine |
GM-Tg-equg-T07931-Ab-1/ GM-Tg-equg-T07931-Ab-2 | Anti-Equine ATAD1/LILRB2/CD85d monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T07931-Ab-1/ GM-Tg-hg-T07931-Ab-2;
GM-Tg-rg-T07931-Ab-1/ GM-Tg-rg-T07931-Ab-2;
GM-Tg-mg-T07931-Ab-1/ GM-Tg-mg-T07931-Ab-2; GM-Tg-cynog-T07931-Ab-1/ GM-Tg-cynog-T07931-Ab-2; GM-Tg-felg-T07931-Ab-1/ GM-Tg-felg-T07931-Ab-2; GM-Tg-cang-T07931-Ab-1/ GM-Tg-cang-T07931-Ab-2; GM-Tg-bovg-T07931-Ab-1/ GM-Tg-bovg-T07931-Ab-2; GM-Tg-equg-T07931-Ab-1/ GM-Tg-equg-T07931-Ab-2 |
Products Name | Anti-ATAD1/LILRB2/CD85d monoclonal antibody |
Format | mab |
Target Name | ATAD1/LILRB2/CD85d |
Protein Sub-location | Transmembrane Protein |
Category of antibody | Therapeutics Target |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) |
IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-ATAD1/LILRB2/CD85d monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data/case study
Click to get more Data/Case study about the product.
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.
Comments
No comments yet.